types of glp-1 Medications for Weight Loss: Differences, Uses & Safety GLP-1 Drug Comparison in Diabetes

Lancet 342 , 337338 (1993)

Doseresponse effect of interleukin (IL)-1, tumour necrosis factor (TNF)-, and interferon- on the in vitro production of epithelial neutrophil activating peptide-78 (ENA-78), IL-8, and IL-6 by human endometrial stromal cells

Pharmacologic Implications DPP-4 inhibitors comprise a class of non-insulin anti-diabetic therapeutic interventions that enhance insulin secretion by pancreatic -cells and act by blocking the enzymatic action of DPP-4

The good news is that there are several lower-cost paths if you know where to look

Endotoxin, tumor necrosis factor- and interleukin 1 induce interleukin 6 production in vivo

Rheb is a critical regulator of autophagy during myocardial ischemia: pathophysiological implications in obesity and metabolic syndrome